[ad_1]
It will still be a long time before the European Medicines Agency (EMA) concludes the review of the Russian vaccine against Covid Sputnik V. This was stressed in an interview with the newspaper ‘Berliner Zeitung’ Kirill Dmitriev, CEO of the Russian Investment Fund direct (Rdif), which played an important role in the development of the vaccine.
“If approved, probably after June, we will be able to deliver 100 million doses to 50 million people in the EU within three to four months,” Dmitriev said. Russia hopes that, after Hungary, other EU countries will approve the vaccine regardless of the EMA’s evaluation. The general director of the Russian sovereign wealth fund, which is in charge of the international distribution of the vaccine, explained that the first doses could arrive as of next month in the states that give the green light to the vaccine.
“We are now expecting a delegation from the EMA in mid-April and we expect the decision on Sputnik V to be purely scientific, not political,” he added. Dmitriev later confirmed plans to produce the vaccine in Germany and other European countries.
[ad_2]
